Skip to main content

Table 1 Diaphragmatic heights, and diaphragmatic elevation differences in both groups (mean ± SD).

From: Exploring strategies to prevent post-lobectomy space: transient diaphragmatic paralysis using Botulinum Toxin Type A (BTX-A)

 

Control group

BTX-A group

P value

Preop diaphragmatic heights (mm)

23.8 ± 5.4

24.8 ± 5.7

NS

Postop 7th day diaphragmatic heights (mm)

25.2 ± 4.4

31.8 ± 4.3

0.045

Elevation difference (mm)

1.3 ± 1.2*

7.0 ± 2.4

0.0035

Back to article page

International Seminars in Surgical Oncology

ISSN: 1477-7800